Utah Medical Products extends tender offer to Oct. 27

Utah Medical Products, Inc. (UTMD) extended the expiration date of its issuer tender offer from October 7, 2026, to October 27, 2026.

Rhea-AI Filing Summary

Utah Medical Products, Inc. (UTMD) extended the expiration date of its issuer tender offer from October 7, 2026, to October 27, 2026. The company offers to purchase up to 650,000 shares of common stock at $75.00 per share, or a lesser number of shares validly tendered and not withdrawn.

Key Figures

Tender offer size: 650,000 shares Tender offer price: $75.00 per share Tender offer expiration date: October 27, 2026

3 metrics

Tender offer size 650,000 shares Maximum number of shares the company offers to purchase

Tender offer price $75.00 per share Price offered for shares

Tender offer expiration date October 27, 2026 Extended from October 7, 2026

Key Terms

issuer tender offer, Letter of Transmittal, validly tendered and not withdrawn

3 terms

issuer tender offer regulatory

"issuer tender offer subject to Rule 13e-4"

An issuer tender offer is when a company offers to buy back its own shares directly from shareholders at a set price for a limited time, much like a store running a cash-for-items promotion. It matters to investors because it can raise the share price, change how much of the company each remaining shareholder owns, signal management’s view of the company’s value, and affect taxable events and liquidity for those who sell or hold.

Letter of Transmittal financial

"related Letter of Transmittal"

A letter of transmittal is a written form investors use when sending physical stock certificates or electronic ownership documents to a company or its agent to surrender shares, tender them in an offer, or claim payment or replacement securities. It acts like a packing slip that lists what is enclosed, gives instructions on how the transfer should be handled, and provides proof of the transaction—important for ensuring investors receive the correct payment or new securities without delay or dispute.

validly tendered and not withdrawn regulatory

"shares as are validly tendered and not withdrawn"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is the UTMD tender offer price and share limit?

Utah Medical Products offers to purchase up to 650,000 shares of common stock at $75.00 per share, or a lesser number of shares validly tendered and not withdrawn.

When does the UTMD tender offer expire?

The expiration date is October 27, 2026, extended from October 7, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/05/2026 - 12:08 PM Accepted by SEC EDGAR 10/05/2026 - 11:41 AM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

SCHEDULE TO-IA

Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934

Utah Medical Products, Inc.
--------------------------
(Name of Issuer)

Utah Medical Products, Inc. (Issuer)
------------------------------------
(Name of Filing Persons)

Common Stock, Par Value $.01 Per Share
--------------------------------------
(Title of Class of Securities)

917488108
------------------------------------
(Cusip Number of Class of Securities)

Kevin L. Cornwell, Chairman and CEO
Utah Medical Products, Inc.
7043 South 300 West
Midvale, Utah 84047
(801-566-1200)

 (Name, address and telephone numbers of person authorized to receive notices and communications on behalf of filing persons)

[ ] Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer Check the appropriate boxes below to designate any transaction to which the statement relates:

[ ]      third-party tender offer subject to Rule 14d-1.
[x]     issuer tender offer subject to Rule 13e-4.
[ ]      going-private transaction subject to Rule 13e-3
[ ]      amendment to Schedule 13D under Rule 13d-2

Check the following box if the filing is a final amendment reporting the results of the tender offer: [ ]

Introduction

    This Tender Offer Amendment on Schedule TO-IA relates to the tender offer by Utah Medical Products, Inc., a Utah corporation ("UTMD" or the "Company"), to purchase 650,000 shares, or such lesser number of shares as are validly tendered and not withdrawn, of its Common Stock, par value $.01 per share, at a price of $75.00 per Share, upon the terms and subject to the conditions set forth in the Offer to Purchase dated September 24, 2026 the "Offer to  Purchase"), and in the related Letter of Transmittal which, as they may be amended from time to time, together constitute the "Offer".  This Schedule TO-IA is intended to satisfy the reporting requirements of Rule 13e-4(c)(1) of the Securities Exchange Act of 1934, as amended.

1

AMENDMENT

All references to the October 7, 2026 Expiration Date in the Schedule TO-IA filed on September 29, 2026 are hereby extended to October 27, 2026.  

SIGNATURE
        After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

UTAH MEDICAL PRODUCTS, INC.

By: /s/ KEVIN L. CORNWELL                              

Name:    Kevin L. Cornwell

Title:      Chairman and Chief Executive Officer

Date: October 5, 2026

2